Serial #86444513
LIVE

Serial Number

86444513

Owner

H. Lundbeck A/S

Attorney

Maren C. Perry

Filing Date

Nov 4, 2014

Add to watchlist:

No watchlists yet
View on USPTO

Serial #86444513 Trademark

Serial Number: 86444513 • Registration: 4862096

Serial #86444513 is a trademark filed by H. Lundbeck A/S on November 4, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

November 4, 2014

Registration Date

December 1, 2015

Published for Opposition

September 15, 2015

Goods & Services

[ Scientific and technological services, namely, scientific research in the field of medicine; industrial analysis in the nature of research services in the field of pharmaceuticals; providing online non-downloadable software in the field of research and development for use in database management in the field of the treatment and prevention of brain and central nervous system diseases and disorder and an online searchable database in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention for the purpose of scientific research; providing a secured-access website that gives registered medical experts the ability to upload, view, download, and share documents and images for the purposes of research and development in the field of clinical tests and trials, science, patient diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease; pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, diseases and prevention of disease; scientific and technological services, namely, scientific research in the field of the treatment and prevention of brain and central nervous system related disorders, diseases and pharmaceuticals; medical research, conducting clinical medical trials and testing in the field of pharmaceuticals for others; medical services, namely, medical research; medical diagnostic research and tests, namely, clinical trials for others; ] providing medical research information in the field of pharmaceutical research and development, clinical tests and trials

[ Vaccines; ] pharmaceutical preparations and substances for the [ prevention and ] treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; [ central nervous system stimulants; ] pharmaceutical preparations and substances for the [ prevention and ] treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of [ Alzheimer's disease and disorder, stroke, ] depression, mood disorders, psychosis and anxiety [, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; medical diagnostic preparations for medical purposes, reagents for medical use, diagnostic agents preparations and substances for medical purposes ]

[ Education services, namely, providing continuing medical education courses; providing of training, namely, medical training and teaching; arranging and conducting educational seminars, conferences, symposiums, workshops, training and courses in the field of medicine; educational classes, courses, seminars and workshops and training services in the field of research and development for the treatment and prevention of brain and central nervous system diseases and disorders, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational services, namely, seminars, conferences, symposiums, workshops, training and courses and training services in the field of medical research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease provided electronically, on-line, via the Internet and global communications networks; education services, namely, arranging and conducting of expert forums, in the form of seminars, conferences, symposia, workshops and courses in the field of medicine; educational services, namely, providing medical training online; ] providing non-downloadable, on-line publications, namely, [books, ] reports, brochures, booklets, leaflets, including patient information leaflets, [ magazines, journals, teaching and educational material in the nature of articles, journals ] in the field of medical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease

Medical services in the field of psychiatry and psychology, namely, medical advice related to medical and pharmaceutical preparations and substances; [ medical clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; medical treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; ]healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing information relating to [ diagnostic and ] therapeutic properties of pharmaceuticals in the field of disorders, diseases, treatment and prevention; providing medical information services; providing on-line medical data and analyses designed to provide patients and clients customized information, including medical dose, diagnosis, therapeutic issues and medical management

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 26, 2026 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Feb 26, 2026 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Feb 26, 2026 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 23, 2026 APRE
TEAS SECTION 8 & 9 RECEIVED
Nov 26, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 1, 2024 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 22, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 22, 2024 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Mar 22, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 22, 2024 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Mar 20, 2023 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Mar 20, 2023 8.OK
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jan 20, 2023 EROP
POST REGISTRATION ACTION MAILED - SEC. 8
Jul 20, 2022 PRA8
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 8, 2022 APRE
POST REGISTRATION ACTION CORRECTION
May 7, 2022 XXXX
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
May 7, 2022 NAS8
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 7, 2022 APRE
TEAS SECTION 8 RECEIVED
Nov 30, 2021 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 1, 2020 REM1
REGISTERED - SEC. 7 REQUEST ABANDONED
Dec 28, 2015 PRA7
REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED
Dec 28, 2015 CORV
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 28, 2015 APRE
TEAS SECTION 7 REQUEST RECEIVED
Dec 10, 2015 ES7R
REGISTERED-PRINCIPAL REGISTER
Dec 1, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 15, 2015 NPUB
PUBLISHED FOR OPPOSITION
Sep 15, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 11, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 6, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 6, 2015 CRFA
ASSIGNED TO LIE
Jul 29, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 10, 2015 GNRN
NON-FINAL ACTION E-MAILED
Feb 10, 2015 GNRT
NON-FINAL ACTION WRITTEN
Feb 10, 2015 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2015 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 15, 2014 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2014 NWOS
NEW APPLICATION ENTERED
Nov 7, 2014 NWAP